Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells

Accumulating evidence suggests that metformin, a biguanide class of anti-diabetic drugs, possesses anti-cancer properties and may reduce cancer risk and improve prognosis. However, the mechanism by which metformin affects various cancers, including renal cancer still unknown. MiR-26a induces cell gr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Clin Exp Med
Autori principali: Yang, Feng-Qiang, Wang, Ji-Jiao, Yan, Jia-Sheng, Huang, Jian-Hua, Li, Wei, Che, Jian-Ping, Wang, Guang-Chun, Liu, Min, Zheng, Jun-Hua
Natura: Artigo
Lingua:Inglês
Pubblicazione: e-Century Publishing Corporation 2014
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4238495/
https://ncbi.nlm.nih.gov/pubmed/25419360
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi